INFORM DIAGNOSTICS INC. NPI 1467433292

NPI Information

  • NPI: 1467433292
  • Provider Name: INFORM DIAGNOSTICS, INC.
  • Classification: Pathology - 207ZP0102X
  • Specialization: Anatomic Pathology & Clinical Pathology
  • Entity Type: Organization
  • :
  • Address: 1111 S FREEPORT PKWY
    COPPELL, TX
    ZIP 75019
  • Phone: (866) 588-3280

Map and Directions

Get Directions

NPI Details

INFORM DIAGNOSTICS, INC. is an anatomic pathology and clinical pathology pathology in Coppell, TX. The provider is a pathologist deals with the causes and nature of disease and contributes to diagnosis, prognosis and treatment through knowledge gained by the laboratory application of the biologic, chemical and physical sciences. A pathologist uses information gathered from the microscopic examination of tissue specimens, cells and body fluids, and from clinical laboratory tests on body fluids and secretions for the diagnosis, exclusion and monitoring of disease. INFORM DIAGNOSTICS, INC. NPI is 1467433292. The provider is registered as an organization entity type and is a single specialty group.
The provider .

The provider's business location address is:

1111 S FREEPORT PKWY
COPPELL, TX
ZIP 75019-435
Phone: (866) 588-3280

The provider's authorized official is Raymond Christopher Wicker .
The authorized official title is Vice President & General Manager and has the following contact phone number (678) 477-4402.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Pathology examination of tissue using a microscope, intermediate complexity (HCPCS:88305)
  • Flow cytometry technique for dna or cell analysis, each additional marker (HCPCS:88185)
  • Special stained specimen slides to examine tissue, initial procedure (HCPCS:88342)
  • Special stained specimen slides to examine tissue including interpretation and report (HCPCS:88313)
  • Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r (HCPCS:U0003)
  • Special stained specimen slides to identify organisms including interpretation and report (HCPCS:88312)
  • Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source (HCPCS:G2023)
  • Special stained specimen slides to examine tissue, each additional procedure (HCPCS:88341)
  • Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within (HCPCS:U0005)
  • Microscopic genetic analysis of tumor, manual (HCPCS:88360)
  • Microscopic genetic analysis of tissue, manual, each additional multiplex stain procedure (HCPCS:88377)
  • Cell examination of specimen, selective cellular enhancement technique (HCPCS:88112)
  • Pathology examination of tissue using a microscope, moderately low complexity (HCPCS:88304)
  • Flow cytometry technique for dna or cell analysis, 16 or more markers (HCPCS:88189)
  • Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method (HCPCS:G0416)
  • Dna testing for genetic defects (HCPCS:88271)
  • Preparation of tissue for examination by removing any calcium present (HCPCS:88311)
  • Flow cytometry technique for dna or cell analysis, first marker (HCPCS:88184)
  • Tissue culture for tumor disorders of bone marrow and blood cells (HCPCS:88237)
  • Microscopic genetic analysis of tumor, using computer-assisted technology (HCPCS:88361)
  • Chromosome analysis for genetic defects, analyze 20-25 cells (HCPCS:88264)
  • Chromosome analysis for genetic defects, analyze 100-300 cells (HCPCS:88275)
  • Bone marrow, smear interpretation (HCPCS:85097)
  • Translocation analysis (bcr/abl1) major breakpoint (HCPCS:81206)
  • Special stained specimen slides to examine tissue, each multiplex procedure (HCPCS:88344)
  • Microscopic genetic analysis of tissue, manual, each additional procedure (HCPCS:88369)
  • Molecular pathology procedure (HCPCS:81479)
  • Microscopic genetic analysis of tissue, manual, initial procedure (HCPCS:88368)
  • Genetic sequencing localization, initial procedure (HCPCS:88365)
  • Genetic sequencing localization, each additional procedure (HCPCS:88364)
  • Gene analysis (janus kinase 2) variant (HCPCS:81270)
  • Gene analysis (calreticulin), common variants (HCPCS:81219)
  • Gene analysis (mpl proto-oncogene, thrombopoietin receptor) for detection of common variants (HCPCS:81338)
  • Chemical analysis of stone (HCPCS:82360)
  • Pathology examination of tissue using a microscope, moderately high complexity (HCPCS:88307)
  • Gene analysis (janus kinase 2) targeted sequence analysis (HCPCS:81279)
  • Pathology examination of tissue using a microscope, limited examination (HCPCS:88300)
  • Evaluation of fine needle aspirate with interpretation and report (HCPCS:88173)
  • Surgical pathology consultation and report on referred slides prepared elsewhere (HCPCS:88321)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test (HCPCS:85027)
  • Chromosome analysis for genetic defects, additional cells counted, each study (HCPCS:88285)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Gene rearrangement analysis (immunoglobulin heavy chain locus), variable region somatic mutation analysis (HCPCS:81263)
  • Bacterial culture, any other source except urine, blood or stool, aerobic (HCPCS:87070)
  • Surgical pathology consultation and report on referred material requiring preparation of slides (HCPCS:88323)
  • Gene analysis (myeloid differentiation primary response 88) for p.leu265pro variant (HCPCS:81305)
  • Flow cytometry technique for dna or cell analysis, 9 to 15 markers (HCPCS:88188)
  • Translocation analysis (bcr/abl1) minor breakpoint (HCPCS:81207)
  • Cell examination of body fluid, smears (HCPCS:88104)
  • Bacterial culture for aerobic isolates (HCPCS:87077)
  • Pathology examination of tissue using a microscope (HCPCS:88302)
  • Interpretation and report of genetic testing (HCPCS:88291)
  • Evaluation of antimicrobial drug (antibiotic, antifungal, antiviral), microdilution or agar dilution (HCPCS:87186)
  • Gene analysis (v-raf murine sarcoma viral oncogene homolog b1) (HCPCS:81210)
  • Enzyme activity measurement, nonradioactive substrate (HCPCS:82657)
  • Cell examination of urine, manual (HCPCS:88120)

The enumeration date for this NPI number is 11/9/2005 and was last updated on 4/8/2025.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207ZP0102XPathologyAnatomic Pathology & Clinical PathologyYes
2291U00000XClinical Medical LaboratoryNo

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.